Skip to main content

Volume 11 - Issue 9 - September 2014

September 2014 Issue 9 Volume 11


Interview by Jennifer Ford

The injectable foam Varithena was recently approved by the FDA for treatment of varicose veins. Vascular Disease Management speaks about the therapy with Dr. Marlin Schul, who participated in a trial that led to its approval.
Vascular Disease Management presents abstracts from research and data presented at the 4th Annual Amputation Prevention Symposium held in Chicago in August.
Case Report

Sohail Khan, MD; Hamid Salam, MD; John Kessels, MD, From St. Tammany Parish Hospital, Covington, Louisiana.

The authors present a case of a 58-year-old female who developed popliteal occlusion post total knee arthroplasty.
Endovascular Techniques

Parag Patel, MD1; Joseph Zechlinski, MD1; Jeff Elbich, MD2
From 1Medical College of Wisconsin, Milwaukee, and 2Medical College of Virginia, Richmond.

Success for endovascular aneurysm repair when endoleaks occur hinges on correct identification and treatment of the endoleak. The authors present techniques for repairing refractory type II endoleaks.
Endovascular Techniques

Luis Mariano Palena, MD; Marco Manzi, MD, From the Interventional Radiology Unit, Foot and Ankle Clinic, Policlinico Abano Terme, Abano Terme Padova, Italy.

Below-the-knee and below-the-ankle revascularization can be unsuccessful in 20% of cases, highlighting the need for more refined technique. The authors present a comprehensive overview of retrograde access for critical limb ischemia involving the foo…
Editor's Corner

Craig Walker, MD

Patients with critical limb ischemia who have obstructions in the foot have among the poorest prognosis. Retrograde access can help revascularize the foot and save limbs.
Back to Top